The global oligonucleotide synthesis market was valued at $5,197.50 million in 2020, and is projected to reach $26,099.90 million by 2030, registering a CAGR of 17.10% from 2022 to 2028.
The chemical synthesis of relatively short segments of nucleic acids with defined chemical structure is known as oligonucleotide synthesis (sequence). The method is particularly valuable in today’s laboratory since it allows for quick and low-cost access to custom-made oligonucleotides of the appropriate sequence. It can also be used for molecular diagnosis in a variety of disorders, including the identification of infectious diseases like hepatitis and SARS-COV2, as well as cancer diagnosis.
Access Full Report here : https://www.zionmarketresearch.com/report/oligonucleotide-synthesis-market
COVID-19 has caused widespread disruption in healthcare workflows around the world. Various industries, including several sub-domains of healthcare, have been forced to temporarily close their doors because to the sickness. There has, however, been a favourable effect and an increase in demand for many medical services, including oligonucleotide products. Oligo products are necessary for the development of test kits, therapies, and vaccinations to combat the new Coronavirus illness. Furthermore, new generations of oligonucleotide therapeutics, including mRNA and DNA vaccines, are now being developed in response to the rise in incidence of coronavirus illness (COVID-19) and the need for a viable cure.
A major driver driving the growth of the oligonucleotide synthesis industry is the increase in government financing for synthetic biology and genome projects, as well as vigorous research. In addition, pharmaceutical and biotechnology companies are investing in R&D to develop oligonucleotide products with greater therapeutic potential and fewer side effects, which is propelling the market forward. Furthermore, expanding applications of synthesised oligonucleotides in molecular diagnostics and clinical applications, as well as an increase in demand for high-end customised oligos and improvements in synthetic oligonucleotide purification, all contribute to the market’s growth. On the contrary, the complexities of therapeutic oligos and the difficult delivery of oligonucleotide medications to specific targets may stymie the market for oligonucleotide production. However, the industry is expected to benefit from development possibilities in emerging nations and a growing focus on personalised treatment.
Market Segmentation for Oligonucleotide Synthesis
Oligonucleotide synthesis Market, by Product
● Oligonucleotide-based drugs
● Synthesized oligonucleotides
Oligonucleotide synthesis Market, by Application
● Therapeutic applications
● Research applications
An Overview of the Oligonucleotide Synthesis Market in Asia-Pacific
Due to constantly developing healthcare infrastructure, economic development, and increased government support and investment, Asia-Pacific is predicted to grow at the quickest rate during the projection period. Increased government support and investment for improving people’s health, as well as an increase in cases of chronic conditions such as COVID-19, cardiovascular disease, cancer, and others, accelerate market growth. For example, the Department of Biotechnology (DBT) launched the “Genome India Project” in January 2020. (GIP). The goal of the initiative is to collect 10,000 genetic samples from Indian residents in order to create a reference genome.
The key market players profiled in the report include Alnylam Pharmaceuticals, Inc., Biogen Inc., Danaher Corporation, Eurofins Scientific, Ionis Pharmaceuticals, Inc., Kaneka Corporation, LGC Limited, Merck KGAA, Sarepta Therapeutics, Inc., Thermo Fisher Scientific, Inc.
Stakeholders’ Key Benefits
• The research includes an in-depth examination of the global oligonucleotide synthesis industry, as well as current trends and forecasts, in order to identify potential investment opportunities.
• The study includes a detailed examination of the factors that drive and limit the growth of the oligonucleotide synthesis industry.
• The report provides a comprehensive quantitative analysis of the industry from 2020 to 2028, allowing players to benefit on current market opportunities.
• An in-depth examination of the industry’s core segments aids in understanding the applications and products of oligonucleotide synthesis used around the world.
• To understand the competitive landscape of the industry, key market players and their strategies have been examined.
About Us :
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database.